FDA Approved Drug ‘Tecentriq’ to Treat Bladder Cancer

FDA Approved Drug 'Tecentriq' to Treat Bladder Cancer - Health Council

There’s a new drug approved by the FDA for bladder cancer:

“Tecentriq (atezolizumab) treats the most common type of bladder cancer, called urothelial carcinoma. It’s the first in its class of drugs, called PD-1/PD-L1 inhibitors, approved to treat this type of cancer.”

Read the full article: FDA Approves New Drug to Treat Bladder Cancer